成人起病Still病伴神经系统受累的单中心回顾性研究
该单中心回顾性研究纳入2015年1月至2019年8月北京协和医院收治的187例成人起病Still病(AOSD)患者,其中14例(7.5%)存在神经系统受累。神经系统受累者MAS发生率、乳酸脱氢酶和铁蛋白水平显著高于无神经系统受累者,所有14例经大剂量糖皮质激素联合免疫抑制剂治疗后均达到临床缓解。
要点
- AOSD住院患者神经系统受累患病率为7.5%,无菌性脑膜炎最常见(64.3%)。
- 神经系统受累者MAS发生率及LDH、铁蛋白水平显著高于无神经系统受累者。
- 所有神经系统受累患者经大剂量激素联合免疫抑制剂治疗均达临床缓解。
核心结论
- 神经系统受累,尤其无菌性脑膜炎,并非AOSD罕见并发症,且常合并MAS。
- AOSD神经系统损害与MAS之间可能存在潜在关系。
研究设计与样本
- 单中心回顾性研究,纳入2015年1月至2019年8月北京协和医院187例AOSD住院患者,回顾完整病历,比较14例伴神经系统受累者与无受累者的临床特征。
主要发现
- 神经系统受累患病率为7.5%,中位病程4.5个月(范围1–15个月)。
- 常见症状为发热14例(100%)、皮疹13例(92.9%)、肝功能障碍11例(78.6%)、关节痛/关节炎10例(71.4%)、淋巴结肿大10例(71.4%)。
- 4例(28.6%)合并MAS;无菌性脑膜炎为最常见神经系统表现(64.3%),其他少见表现包括颅神经麻痹、脑炎和脑梗死。
- 伴神经系统受累者MAS发生率、血清乳酸脱氢酶和铁蛋白水平显著高于无受累者。
- 所有患者接受大剂量糖皮质激素和免疫抑制剂治疗,2例加用托珠单抗,14例均达到临床缓解。
临床怎么用
- AOSD患者出现神经系统症状时应警惕无菌性脑膜炎等受累,并评估合并MAS的可能。
- 对伴神经系统受累的AOSD患者,可采用大剂量糖皮质激素联合免疫抑制剂治疗,必要时加用托珠单抗。
局限性
- 单中心回顾性研究,样本量有限,伴神经系统受累者仅14例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Adult-onset Still's disease (AOSD) is a multifactorial systemic autoinflammatory disease. Neurological damage has been rarely reported in AOSD. We aimed to characterize the clinical features of AOSD patients with neurological involvement. METHODS: A total of 187 AOSD patients were admitted to Peking Union Medical College Hospital from January 2015 to August 2019. The complete medical records were reviewed in this retrospective study. Clinical features of 14 AOSD patients with neurological involvement were collected and compared with those without. RESULTS: The prevalence of neurological involvement in AOSD inpatients was 7.5%. The median disease duration was 4.5 months, with a range of 1-15 months. The frequent symptoms were fever [14 (100%)], rash [13 (92.9%)], liver dysfunction [11 (78.6%)], arthralgia/arthritis [10 (71.4%)] and lymphadenopathy [10 (71.4%)]. Four (28.6%) patients had macrophage activation syndrome (MAS). Aseptic meningitis was the most common presentation (64.3%) when the nervous system was involved. Other rare manifestations included cranial nerve palsy, encephalitis and cerebral infarction. The rate of MAS, serum levels of lactate dehydrogenase and ferritin were significantly higher in AOSD patients with neurological involvement than in those without. All patients received high-dose corticosteroid therapy and immunosuppressive agents and two were given tocilizumab. Clinical remission was achieved in all 14 AOSD patients with neurological involvement. CONCLUSION: Neurological involvement, particularly aseptic meningitis, is not a rare complication of AOSD. It is frequently complicated by MAS. There may be a potential relationship between the neurological damage of AOSD and MAS.
引用
- Zhao M, Wu D, Shen M, et al. Adult-onset Still's disease with neurological involvement: a single-centre report. Rheumatology (Oxford). 2021. PMID: 33369675. doi:10.1093/rheumatology/keaa899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。